Weaker Buy Today XLRN ranks #536 as BUY CANDIDATE #536 Stronger Buy

XLRN stock forecast Acceleron Pharma Inc.

XLRN stock forecast

Wednesday May 22, 2019 Change 0.82% Price $43.25
Chart period: 2019-02-25 - 2019-05-22
VOLUME
Buy
TREND
Sell
MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Will XLRN stock price go up or down on Thu, 23 May 2019?

Predict

Acceleron Pharma Inc. Forecast and Stock Analysis

Technical XLRN stock analysis for Wednesday May 22, 2019.

Buy candidate since 2019-05-21 Gain 0.82%
Shorts n/a
Insider % n/a
Institutional % n/a
Beta 1.49
ROA -29.13%
Price to book USD 4.23
P/E Ratio -15.69
Next Earnings Date 2019-08-04


Acceleron Pharma Inc. gained 0.82% in the last trading day ( Wednesday, 22nd May 2019 ), rising from $42.90 to $43.25 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During day the stock fluctuated 3.88% from a day low at $41.74 to a day high of $43.36. The price has fallen in 5 of the last 10 days , but is still up by 5.38% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 3 828 more shares were traded than the day before. In total, 269 312 shares bought and sold for approximately $11.65 million.

Quick summary:

  • 30 day high of the XLRN stock price was $43.36 and low was $39.24.
  • 90 day high was $48.11 and low was $38.65.
  • 52 week high for the Acceleron Pharma Inc. - $59.59 and low - $32.53.

Trend

Acceleron Pharma Inc. lies the upper part of a wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $43.70 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -11.69% during the next 3 months and, with 90% probability hold a price between $33.12 and $38.59 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Acceleron Pharma Inc. holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $41.94 and $42.15. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday May 20, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 65 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Acceleron Pharma Inc. finds support from accumulated volume at $42.29.

Support: $42.29 Price: $43.25 Resistance: $44.04

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.62 (3.88%) between high and low. For the last week, the stock has had a daily average volatility of 3.31%.

Our recommended stoploss: $41.54 (-3.94%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 2 days ago.)

3.31 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Weaker Buy Today XLRN ranks #536 as BUY CANDIDATE #536 Stronger Buy
XLRN $43.25 ($0.35 0.82%)
XLRN is up $0.35 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for XLRN based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for StockInvest.us readers.

Click here – the XLRN analysis is free »

Will XLRN stock price go up or down
on Thu, 23 May 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank